CME Group (CME) Stock Seems Overvalued After Its 65% Five Year Run

CME Group has ridden a powerful five year run, and the question now is whether that price momentum lines up with the returns the business earns on the capital tied up in its clearinghouses and trading infrastructure. Over the past 5 years the stock has returned 64.5%, which puts real weight on whether those gains are backed by strong profitability on the equity and cash invested in the exchange platform. The planned futures tied to AI computing power, along with expanding contracts in areas...